Antibe Therapeutics Reports 2016 Year-End Financial And Operating Results
TORONTO--(BUSINESS WIRE)--Antibe Therapeutics Inc. ("Antibe") (TSXV:ATE, OTCQX:ATBPF) filed its financial and operating results Friday, July 29 for the fourth quarter and the year ended March 31, 2016. The Corporation's audited 2016 financial statements, MD&A and AIF are available on SEDAR.